Skip to main content

Table 4 Multivariate analysis of clinical features and ERβ1 expression (Allred) with recurrence

From: Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Feature (reference)

HR [CI 95%]

p value

ERβ1 Allred 1–4 (vs. ERβ1 Allred 0)

0.57 [0.20–1.58]

0.279

ERβ1 Allred 5 + (vs. ERβ1 Allred 0)

1.04 [0.42–2.58]

0.938

Agea

1.02 [0.99–1.05]

0.051

Stage IIA

4.37 [1.42–13.47]

0.0101*

Stage IIB

4.24 [1.25–26.21]

0.0201*

Stage III/IV

7.78 [2.31–26.21]

0.0009*

Chemotherapy Yes (vs. no)

0.46 [0.21–1.04]

0.062

  1. Footnote: aContinuous (years). * P<0.05